Skip to main content
. 2014 Jan 7;12:7. doi: 10.1186/1479-5876-12-7

Table 2.

Correlation of peritumoral CD66+ neutrophils, CD8+ lymphocytes and NLR with clinicopathological parameters

  Total
 Peritumoral neutrophils a
Peritumoral CD8+ lymphocytes a
Peritumoral NLR
90 Low High P value Low High P value <l ≥1 P value
Gender
  
  
  
  
  
  
  
  
  
  
Male
 72
 38
 34
 0.292
 37
 35
 0.598
 40
 32
 0.009
Female
 18
 7
 11
  
 8
 10
  
 16
 2
  
Age
 42-78
  
  
  
  
  
  
  
  
  
<60.5b
 45
 25
 20
 0.292
 25
 20
 0.292
 27
 18
 0.664
≥60.5
 45
 20
 25
  
 20
 25
  
 29
 16
  
Tumor location
  
  
  
  
  
  
  
  
  
  
Upper
 10
 6
 4
 0.612
 6
 4
 0.769
 6
 4
 0.634
Middle
 48
 25
 23
  
 24
 24
  
 28
 20
  
Lower
 32
 14
 18
  
 15
 17
  
 22
 10
  
Tumor length
 0.5-8.5
  
  
  
  
  
  
  
  
  
<4.0b
 52
 18
 26
 0.092
 20
 24
 0.399
 30
 14
 0.254
≥4.0
 38
 27
 19
  
 25
 21
  
 26
 20
  
Differential grade
  
  
  
  
  
  
  
  
  
  
Well
 25
 9
 16
 0.185
 14
 11
 0.764
 12
 13
 0.221
Middle
 39
 20
 19
  
 19
 20
  
 26
 13
  
Poor
 26
 16
 10
  
 12
 14
  
 18
 8
  
T stage
  
  
  
  
  
  
  
  
  
  
1 and 2
 31
 18
 13
 0.267
 12
 19
 0.12
 27
 4
 <0.001
3 and 4
 59
 27
 32
  
 33
 26
  
 29
 30
  
LN metastasis
  
  
  
  
  
  
  
  
  
  
Negative
 57
 27
 30
 0.512
 26
 31
 0.274
 40
 17
 0.041
Positive
 33
 18
 15
  
 19
 14
  
 16
 17
  
Positive LN
  
  
  
  
  
  
  
  
  
  
0
 57
 27
 30
 0.764
 26
 31
 0.045
 40
 17
 0.014
1
 12
 7
 5
  
 10
 2
  
 3
 9
  
≥2
 21
 11
 10
  
 9
 12
  
 13
 8
  
pTNM stage
  
  
  
  
  
  
  
  
  
  
I
 18
 9
 9
 0.972
 8
 10
 0.536
 13
 5
 0.053
II
 41
 21
 20
  
 19
 22
  
 29
 12
  
III
 31
 15
 16
  
 18
 13
  
 14
 17
  
Recurrence
  
  
  
  
  
  
  
  
  
  
Yes
 63
 31
 32
 0.818
 32
 31
 0.818
 38
 25
 0.569
No 27 14 13   13 14   18 9  

LN lymph node, pTNM pathological tumor node metastasis, NLR CD66+ neutrophil-to-CD8+ lymphocyte ratio, values in bold signify p < 0.05, aGrouped by median, bThe median.